UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000013163
Receipt No. R000015350
Official scientific title of the study Protocol for BNCT against recurrent head and neck tumors(two)
Date of disclosure of the study information 2014/03/20
Last modified on 2017/02/21 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Protocol for BNCT against recurrent head and neck tumors(two)
Title of the study (Brief title) BNCT against head and neck tumors
Region
Japan

Condition
Condition recurrent head and neck tumors
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 establishment of protocol
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes safty
Key secondary outcomes effectiveness

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine Device,equipment
Interventions/Control_1 boron carrier (drug) and irradiation machine
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit
85 years-old >=
Gender Male and Female
Key inclusion criteria patients who cannot receive standard therapies, and will have severe and untolerable damades following standard therapies.
Key exclusion criteria general condition:poor.
patients who have developed other kinds of cancers or distant metastases.
Target sample size 20

Research contact person
Name of lead principal investigator Junichi Hiratsuka
Organization Kawasaki Medical School
Division name Radiation Oncology
Address 577 Matsushima Kurashiki City
TEL 086-462-1111
Email hiratuka@med.kawasaki-m.ac.jp

Public contact
Name of contact person Remi Kawanishi
Organization Kawasaki Medical School
Division name Devision of Research Support
Address 577 Matsushima Kurashiki City
TEL 086-462-1111
Homepage URL
Email kenkyu-idai@med.kawasaki-m.ac.jp

Sponsor
Institute Junichi Hiratsuka
Institute
Department

Funding Source
Organization MEXT(Japan)
Organization
Division
Category of Funding Organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 03 Month 20 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2014 Year 02 Month 14 Day
Anticipated trial start date
2014 Year 03 Month 20 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 02 Month 14 Day
Last modified on
2017 Year 02 Month 21 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000015350